Synonym
5-Fluoro-UMP; 5-Fluorouridine 5’-monophosphate; 5-Fluorouridine 5’-phosphate; 5-Fluorouridine monophosphate; 5-Fluorouridylic acid
IUPAC/Chemical Name
((2R,3S,4R,5R)-5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate
InChi Key
RNBMPPYRHNWTMA-UAKXSSHOSA-N
InChi Code
InChI=1S/C9H12FN2O9P/c10-3-1-12(9(16)11-7(3)15)8-6(14)5(13)4(21-8)2-20-22(17,18)19/h1,4-6,8,13-14H,2H2,(H,11,15,16)(H2,17,18,19)/t4-,5-,6-,8-/m1/s1
SMILES Code
O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N2C=C(F)C(=O)NC2=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
342.17
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Ward T, Hartzer M, Blumenkranz M, Lin LR. A comparison of 5-fluorouridine and
5-fluorouracil in an experimental model for the treatment of vitreoretinal
scarring. Curr Eye Res. 1993 May;12(5):397-401. doi: 10.3109/02713689309024621.
PMID: 8344064.
2: Škvára P, Santana-Viera S, Montesdeoca-Esponda S, Mordačíková E, Santana-
Rodríguez JJ, Vojs Staňová A. Determination of 5-fluorocytosine, 5-fluorouracil,
and 5-fluorouridine in hospital wastewater by liquid chromatography-mass
spectrometry. J Sep Sci. 2020 Aug;43(15):3074-3082. doi: 10.1002/jssc.202000144.
Epub 2020 Jun 15. PMID: 32432394.
3: Janssen JM, Jacobs BAW, Roosendaal J, Derissen EJB, Marchetti S, Beijnen JH,
Huitema ADR, Dorlo TPC. Population Pharmacokinetics of Intracellular
5-Fluorouridine 5'-Triphosphate and its Relationship with Hand-and-Foot Syndrome
in Patients Treated with Capecitabine. AAPS J. 2021 Jan 8;23(1):23. doi:
10.1208/s12248-020-00533-1. PMID: 33417061.
4: Malecki E, Viere R, Rosemeyer H. Immobilization of 5-fluorouridine on
chitosan. Chem Biodivers. 2013 Oct;10(10):1828-41. doi: 10.1002/cbdv.201300025.
PMID: 24130026.
5: Slusarczyk M, Ferla S, Brancale A, McGuigan C. Synthesis and biological
evaluation of 6-substituted-5-fluorouridine ProTides. Bioorg Med Chem. 2018 Feb
1;26(3):551-565. doi: 10.1016/j.bmc.2017.11.037. Epub 2017 Dec 2. PMID:
29277307.
6: Palomar-Siles M, Heldin A, Zhang M, Strandgren C, Yurevych V, van Dinter JT,
Engels SAG, Hofman DA, Öhlin S, Meineke B, Bykov VJN, van Heesch S, Wiman KG.
Translational readthrough of nonsense mutant TP53 by mRNA incorporation of
5-Fluorouridine. Cell Death Dis. 2022 Nov 25;13(11):997. doi:
10.1038/s41419-022-05431-2. PMID: 36433934; PMCID: PMC9700717.
7: Mori H, Sakamoto O, Kitaichi K, Koda A, Kita J. Novel derivatives of
5-fluorouridine and 5-fluorouracil having potent antitumor and lower
immunosuppressive activities. Jpn J Pharmacol. 1992 Mar;58(3):269-82. doi:
10.1254/jjp.58.269. PMID: 1513076.
8: Spedaliere CJ, Mueller EG. Not all pseudouridine synthases are potently
inhibited by RNA containing 5-fluorouridine. RNA. 2004 Feb;10(2):192-9. doi:
10.1261/rna.5100104. PMID: 14730018; PMCID: PMC1370531.
